This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Experimental Use of a Chemotherapeutic Agent

BRIAN McKIBBIN, FRCS

AMA Arch Surg. 1964;89(4):691-694.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Experiments performed recently in this laboratory^4,6,7 have shown that many anticancer drugs are effective in preventing growth of cancer cells when they are used as irrigants one hour after implantation of cancer cells (Walker 256) into a subcutaneous wound. In experiments to be reported elsewhere⁵ we have noted that two of these compounds (sodium hypochlorite and sodium troclosene [ACL 60, sodium dichloroisocyanurate]) which act locally only, would actually increase the incidence of growth when used to irrigate the peritoneal cavity of rats one hour after implantation with Walker 256 cells. In experiments reported herein we have noted that at least one of these drugs used in our original experiments,⁷ namely A8103 (N,N'-bis-(3-bromopropionyl) piperazine) will decrease the incidence of growth of tumor cells when used as an irrigant in the peritoneal cavity after implantation with Walker 256 cells.

A systemically acting agent such as A8103 has an obvious . . . [Full Text PDF of this Article]

Author Affiliations
CHICAGO

From the Department of Surgery, University of Illinois College of Medicine.

Footnotes
Submitted for publication April 24, 1964.

Supported in part by United States Public Health Service grant No. 3482 and the University of Illinois Foundation.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?